Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Gavrila, L. Chachi, O. Tliba, C. Brightling, Y. Amrani (Leicester, United Kingdom; Philadelphia, United States Of America). Compound A (CpdA) suppressed production of corticosteroid-resistant chemokines via GR-independent mechanisms in airway smooth muscle (ASM) cells. Eur Respir J 2013; 42: Suppl. 57, 681

Member's Comments

No comment yet.

Related content which might interest you: Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Compound A modulates steroid insensitive chemokines in airway smooth muscle cells via IRF-1 dependent and independent pathways Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 MNK-1 inhibition reduces proliferation and CXCL10 in airway smooth muscle cells Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2 Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 IL33 and TNFalpha synergistically enhance store operated Ca2+ entry in cultured human airway smooth muscle cells Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Role of protein phosphatase 5 (PP5) in mediating corticosteroid insensitivity in airway smooth muscle (ASM) cells in severe asthma Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 DP2/CRTh2 is expressed by ASM cells in asthma and its inhibition suppresses ASM migration Source: International Congress 2016 – Mechanisms of disease Year: 2016 HMGB1 is upregulated in ASM in asthma and induces ASM contraction via TLR4 Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM) Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration Source: International Congress 2014 – Cell biology 2014 Year: 2014 WNT-5A and WNT-11 as novel regulators of the contractile airway smooth muscle phenotype Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Eosinophil-induced airway smooth muscle cells remodeling is attenuated by blocking of RGD-binding integrins in asthma Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Upregulation of airway smooth muscle (ASM) cell apoptosis may limit ASM growth during airway remodeling in experimental asthma Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008 TGF-beta alters TRPC6 expression and calcium handling via smad2/3 in human airway smooth muscle Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Effect of oxidative stress on mitochondrial function in airway smooth muscle (ASM) cells from COPD patients Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Mitochondrial reactive oxygen species (ROS) mediate proliferation and cytokine release in airway smooth muscle cells of patients with COPD Source: International Congress 2014 – Cell biology 2014 Year: 2014 A functional role for WNT-5A in driving airway myocyte proliferation Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013